Ovarian Cancer
Showing NaN - NaN of 100
Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)
Completed
- Breast Cancer
- +3 more
- FPA150
- Pembrolizumab
-
Scottsdale, Arizona
- +17 more
Jan 6, 2022
Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)
Completed
- Ovarian Neoplasms
- Ovarian Cancer
-
Chandler, Arizona
- +54 more
Sep 24, 2021
Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)
Completed
- Tumor
- Ovarian Cancer
- NKTR-102 q14d
- NKTR-102 q21d
-
Highland, California
- +19 more
Jul 9, 2021
Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)
Completed
- Brain Tumor
- +8 more
- sodium thiosulfate
- examination
-
Birmingham, Alabama
- +75 more
Jul 1, 2021
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Oklahoma City (Paclitaxel, Cisplatin IP)
Terminated
- Ovarian Cancer
- +3 more
- Paclitaxel, Cisplatin IP
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Apr 28, 2021
Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,
Terminated
- Advanced Solid Tumors
- +2 more
- SY-1365 (Part 1)
- +5 more
-
Birmingham, Alabama
- +19 more
Mar 5, 2021
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (Gemcitabine, pazopanib)
Completed
- Ovarian Cancer
- +2 more
-
Scarborough, Maine
- +7 more
Feb 8, 2021
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,
Completed
- Epithelial Ovarian Cancer
- +3 more
- Mirvetuximab soravtansine
- +3 more
-
Birmingham, Alabama
- +130 more
Sep 24, 2020
Solid Tumors, Ovarian Cancer, Endometrial Cancer Trial in United States (ARQ 092 + carboplatin + paclitaxel (Closed), ARQ 092 +
Terminated
- Solid Tumors
- +2 more
- ARQ 092 + carboplatin + paclitaxel (Closed)
- +2 more
-
Grand Rapids, Michigan
- +4 more
Sep 28, 2020
Ovarian Cancer, Cancer of Ovary, Cancer of the Ovary Trial in Oklahoma City, Dallas, Lubbock (Fenretinide/LXS + Ketoconazole)
Terminated
- Ovarian Cancer
- +4 more
- Fenretinide/LXS + Ketoconazole
-
Oklahoma City, Oklahoma
- +2 more
Aug 25, 2020
Ovarian Cancer Trial in New York, Oklahoma City, Philadelphia (OMP-54F28, Paclitaxel and Carboplatin)
Completed
- Ovarian Cancer
- OMP-54F28, Paclitaxel and Carboplatin
-
New York, New York
- +3 more
Aug 11, 2020
Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer Trial in Worldwide (carboplatin, cisplatin, paclitaxel)
Completed
- Fallopian Tube Cancer
- +3 more
- carboplatin
- +2 more
-
Springfield, Missouri
- +49 more
Mar 31, 2020
Ovarian Cancer Trial in United States (Questionnaire)
Unknown status
- Ovarian Cancer
- Questionnaire
-
Miami, Florida
- +10 more
Nov 1, 2019
Ovarian Cancer, Non Small Cell Lung Cancer, Prostate Cancer Trial in United States (LY2523355, pegfilgrastim)
Completed
- Ovarian Cancer
- +6 more
-
Jonesboro, Arkansas
- +17 more
Sep 9, 2019
Ovarian Cancer Trial in Japan, United States (carboplatin, paclitaxel)
Completed
- Ovarian Cancer
-
Birmingham, Alabama
- +150 more
May 23, 2019
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (enzastaurin HCl)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
- enzastaurin hydrochloride
-
Los Angeles, California
- +15 more
Mar 8, 2019
Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)
Terminated
- Ovarian Cancer
- SC-003
- SC-003 in combination with ABBV-181
-
Fayetteville, Arkansas
- +15 more
Jan 2, 2019
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (topotecan HCl)
Completed
- Fallopian Tube Cancer
- +2 more
- topotecan hydrochloride
-
Hartford, Connecticut
- +77 more
Jun 27, 2018